Source:http://linkedlifedata.com/resource/pubmed/id/18211498
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-23
|
pubmed:abstractText |
BACKGROUND: Oral isotretinoin is currently the most effective therapy for acne, but is associated with numerous adverse effects. To investigate the cardiac effects of isotretinoin, acne patients receiving isotretinoin for 6 months were studied. Methods Twenty-six patients with acne vulgaris were enrolled in the study. The patients were treated with a dose of 0.8 mg/kg/day of isotretinoin (Roaccutane, Hoffman-La Roche, Basle, Switzerland) for 6 months. All participants were assessed pretreatment and at the third month of therapy with 24-h Holter monitoring of electrocardiography. Results Twenty-two patients completed the study (19 females and three males). Initial 24-h Holter monitoring showed normal sinus rhythm in all patients, with a mean heart rate of 79 beats/min (lowest, 63 beats/min; highest, 97 beats/min). At the third month of therapy, 24-h Holter monitoring showed normal sinus rhythm in all patients, with a mean heart rate of 81 beats/min (lowest, 67 beats/min; highest, 91 beats/min). All patients were in sinus rhythm throughout the recording period. None of the patients had supraventricular tachycardia or atrial arrhythmia. Conclusion In this study, 6 months of isotretinoin therapy significantly improved acne and did not cause any cardiac adverse effects at a dose of 0.8 mg/kg/day.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1365-4632
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-7
|
pubmed:dateRevised |
2009-3-5
|
pubmed:meshHeading |
pubmed-meshheading:18211498-Acne Vulgaris,
pubmed-meshheading:18211498-Adult,
pubmed-meshheading:18211498-Arrhythmia, Sinus,
pubmed-meshheading:18211498-Dermatologic Agents,
pubmed-meshheading:18211498-Electrocardiography, Ambulatory,
pubmed-meshheading:18211498-Female,
pubmed-meshheading:18211498-Humans,
pubmed-meshheading:18211498-Isotretinoin,
pubmed-meshheading:18211498-Male,
pubmed-meshheading:18211498-Tachycardia, Supraventricular
|
pubmed:year |
2008
|
pubmed:articleTitle |
Isotretinoin: is there any arrhythmic effect?
|
pubmed:affiliation |
Department of Cardiology, Fatih University, School of Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|